Needham & Company initiates coverage on Hologic (NASDAQ: HOLX) with a Buy and $26 price target, citing a early turnaround ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE